Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Septic shock"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Lascarrou%2C+Jean-Baptiste%22&type=Person&filter%5B%5D=topic_facet%3A%22Septic+shock%22
/vufind/Search/Results?lookfor=%22Lascarrou%2C+Jean-Baptiste%22&type=Person&filter%5B%5D=topic_facet%3A%22Septic+shock%22
Search /vufind/Search2/Results?lookfor=%22Lascarrou%2C+Jean-Baptiste%22&type=Person&filter%5B%5D=topic_facet%3A%22Septic+shock%22
PubPharm (9)
1
Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients : the AdrenOSS-2 phase 2a biomarker-guided trial
enthalten in:
Intensive care medicine
| 2021
von
Laterre, P.
|
Pickkers, P.
|
Marx, G.
| +77
Wird geladen...
2
Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial
enthalten in:
Intensive care medicine
| 2021
von
Laterre, P.
|
Pickkers, P.
|
Marx, G.
| +24
Wird geladen...
3
Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial
enthalten in:
Intensive care medicine
| 2021
von
Laterre, P.
|
Pickkers, P.
|
Marx, G.
| +24
Wird geladen...
4
Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial
enthalten in:
Intensive care medicine
| 2021
von
Laterre, P.
|
Pickkers, P.
|
Marx, G.
| +24
Wird geladen...
5
Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis : a prospective observational multinational study
enthalten in:
Critical care (London, England)
| 2021
von
Blet, A.
|
Deniau, B.
|
Santos, K.
| +52
Wird geladen...
6
Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational study
enthalten in:
Critical care
| 2021
von
Blet, A.
|
Deniau, B.
|
Santos, K.
| +27
Wird geladen...
7
Increased susceptibility to intensive care unit-acquired pneumonia in severe COVID-19 patients : a multicentre retrospective cohort study
enthalten in:
Annals of intensive care
| 2021
von
Llitjos, J.
|
Bredin, S.
|
Lascarrou, J.
| +10
Wird geladen...
8
Increased susceptibility to intensive care unit-acquired pneumonia in severe COVID-19 patients: a multicentre retrospective cohort study
enthalten in:
Annals of intensive care
| 2021
von
Llitjos, J.
|
Bredin, S.
|
Lascarrou, J.
| +10
Wird geladen...
9
Increased susceptibility to intensive care unit-acquired pneumonia in severe COVID-19 patients: a multicentre retrospective cohort study
enthalten in:
Annals of intensive care
| 2021
von
Llitjos, J.
|
Bredin, S.
|
Lascarrou, J.
| +10
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Septic shock
Medienart
9
Aufsätze
8
E-Artikel
8
E-Ressourcen
1
Gedruckte Aufsätze
Zeitschriftentitel
4
Intensive care medicine
3
Annals of intensive care
1
Critical care
1
Critical care (London, England)
Thema
Septic shock
4
Adrecizumab (HAM8101)
4
Adrenomedullin
4
Endothelial function
4
Enibarcimab
3
COVID-19
3
Immunosuppression
3
Journal Article
3
Ventilator-acquired pneumonia
2
Biomarker
2
Biomarkers
2
DPP3
2
Organ dysfunction
2
Outcome
2
Sepsis
1
148498-78-6
1
Antibodies, Monoclonal, Humanized
1
Clinical Trial, Phase II
1
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
1
EC 3.4.14.-
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
Erscheinungsjahr(e)
Von:
Bis:
Sprache
9
Englisch
Haven't found what you're looking for?
Wird geladen...